Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 397 for “"lead compound"”.

  1. Lead compound discovery for myotonic dystrophy

    … treatment. It is understood that CTG expansions lead to formation of stable poly(CUG) mRNA which mislocalize splicing factors such as MBNL1 and lead to missplicing in the cell. One therapeutic strategy is to target such mutant mRNA with small molecules to prevent the sequestration of splicing …

    uiuc Repository record for Lead compound discovery for myotonic dystrophy (opens in a new tab)

  2. The Kinetics of Volatile Lead Compound Formation During Simulated Hazardous Waste Incineration

    … produced anomalous results for air emissions of lead and other metals.</p> <p>To gain a better fundamental understanding of the generation of metal emissions, the kinetics of the formation of volatile pollutants in simulated incinerator kilns were experimentally examined as a function of …

    utk-theses Repository record for The Kinetics of Volatile Lead Compound Formation During Simulated Hazardous Waste Incineration (opens in a new tab)

  3. PARAMETERIZATION OF AN ENERGY MODEL FOR SCORING OF ANTI-HIV DRUGS AND A COMPUTATIONAL METHOD OF LEAD COMPOUND OPTIMIZATION FOR DRUG DISCOVERY

    … This method will be used for in silico compound screening to discover new potential anti-HIV drug candidates. The project also aims to develope a method of optimizing the charges of local parts of a ligand while keeping the rest of the charges roughly constant, rather than attempting to …

    maryland Repository record for PARAMETERIZATION OF AN ENERGY MODEL FOR SCORING OF ANTI-HIV DRUGS AND A COMPUTATIONAL METHOD OF LEAD COMPOUND OPTIMIZATION FOR DRUG DISCOVERY (opens in a new tab)

  4. The Synthesis and Biological Evaluation of Anti-Adhesion Glycoconjugates Against Opportunistic Pathogenic Candida albicans

    … formsof treatment.In this thesis, anti-adhesion compounds of Candida albicansto buccal epithelial cells (BEC) are considered. It was found that glycomimetics built around aromatic scaffolds could be potential anti-adhesion ligands. Using synthetic carbohydrate chemistry and Copper-Catalyzed …

    maynooth Download PDF for The Synthesis and Biological Evaluation of Anti-Adhesion Glycoconjugates Against Opportunistic Pathogenic Candida albicans (opens in a new tab)

  5. Pharmacological Characterization of an Optimized Sigma Receptor Ligand

    … of neurological complications some of which lead to neurodegenerative changes in the brain and hyperthermia. Currently, there are no FDA approved pharmacologic agents to treat the effects of methamphetamine. Recent evidence has suggested methamphetamine may, in part, produce some of its …

    wvu Repository record for Pharmacological Characterization of an Optimized Sigma Receptor Ligand (opens in a new tab)

  6. Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents

    … Anibamine was used as a new anti-prostate cancer lead compound. To discover the pharmacophore, analogs of anibamine were designed using the “deconstruction-reconstruction-elaboration” approach and synthesized. The establishment of a stereoselective route to only one isomer was explored, to …

    vcu Repository record for Synthesis and Evaluation of Anibamine and Its Analogs as Novel Anti-Prostate Cancer Agents (opens in a new tab)

  7. CLINICAL TRANSLATION OF A NOVEL FAPI DIMER [68Ga]Ga-LNC1013

    … and clinical study were conducted to screen the lead compound with the potential for radionuclide therapy. Three new FAPI dimers were synthesized by linking two quinoline-based FAPIs with different spacers. The lead compound, [68Ga]Ga -LNC1013, was then evaluated in a pilot clinical PET imaging …

    nus Repository record for CLINICAL TRANSLATION OF A NOVEL FAPI DIMER [68Ga]Ga-LNC1013 (opens in a new tab) Download file for CLINICAL TRANSLATION OF A NOVEL FAPI DIMER [68Ga]Ga-LNC1013 (opens in a new tab)

  8. SYNTHESIS AND BIOLOGICAL EVALUATION OF CCR5 ANTAGONISTS AS NOVEL ANTI-PROSTATE CANCER AGENTS

    … of PCa cell lines proliferation was explored. A lead compound has been identified which induced 100% inhibition of PCa cell proliferation at micromolar concentrations. Anibamine, the only natural product CCR5 antagonist, was also examined for its anti-proliferative activity and was found to …

    vcu Repository record for SYNTHESIS AND BIOLOGICAL EVALUATION OF CCR5 ANTAGONISTS AS NOVEL ANTI-PROSTATE CANCER AGENTS (opens in a new tab)

  9. Synthesis and Biological Evaluation of Various Derivatives of a Broad-Spectrum Anticancer Nucleoside

    … moyl)amino]-N6-(N-phenylcarbamoyl)adenosine. This compound showed selective toxicity against human colon cancer cells in vitro with LC50's = 6--10 µM. It was hypothesized that the lead compound exerted its cytotoxic effects by interacting with a protein kinase. A systematic Structure Activity …

    byu Repository record for Synthesis and Biological Evaluation of Various Derivatives of a Broad-Spectrum Anticancer Nucleoside (opens in a new tab) Download PDF for Synthesis and Biological Evaluation of Various Derivatives of a Broad-Spectrum Anticancer Nucleoside (opens in a new tab)

  10. Targeting Bacterial and Fungal Pathogens through Novel Glycoconjugate-based Anti-Virulence Strategies

    … presents the synthesis of novel derivatives of lead compounds developed through a combination of synthetic carbohydrate chemistry and Copper-catalysed Azide-Alkyne Cycloaddition (CuAAC). Chapter 2 describes the study of the structural requirements for an interesting intramolecular cyclisation …

    maynooth Download PDF for Targeting Bacterial and Fungal Pathogens through Novel Glycoconjugate-based Anti-Virulence Strategies (opens in a new tab) Embargoed until 2027-01-01

  11. Studies Towards the Development of a Novel Anti-Cancer Agent

    … viride were developed and initially provided a lead compound for testing. Data relating to the anti-inflammatory activity of wortmannin analogues was available in the literature and was used in a computer modelling program SYBYL to build a structure activity relationship from which activity of …

    glasgow Download PDF for Studies Towards the Development of a Novel Anti-Cancer Agent (opens in a new tab)

  12. Pharmacological Stimulation Of The Human Hsp70 Protein Disaggregase System

    … against aggregated luciferase. We show that the lead compound can also stimulate the disaggregase activity of the Hsp70 system against αSyn amyloid fibrils. We found that certain members of the Hsp70 and Hsp40 chaperone families were unable to promote disaggregation and reactivation of soluble …

    penn Repository record for Pharmacological Stimulation Of The Human Hsp70 Protein Disaggregase System (opens in a new tab)

  13. Design, synthesis and biological evaluation of cognitive enhancers acting through the potentiation of the AMPA receptors

    … approach includes three major classes of compounds amongst which appear the benzothiadiazine 1,1-dioxides. The present thesis is a pursuit of the preliminary efforts that were published in 1998 and 2001 by our team. Based on promising in vitro results obtained with the lead compound 59, …

    liege Repository record for Design, synthesis and biological evaluation of cognitive enhancers acting through the potentiation of the AMPA receptors (opens in a new tab) Restricted access

  14. I) SYNTHESIS OF PLASMINOGEN ACTIVATOR (Pla) INHIBITORS IN YERSINIA PESTIS II) DEVELOPMENT OF SMALL MOLECULE INHIBITORS TO RESTORE NUCLEAR p27 AS A THERAPEUTIC METHOD FOR ENDOMETRIAL CANCER

    … and inhibitory assay. Identification of a lead compound was conducted at Harvard Medical School. Derivatization of the lead gave analogs which will be tested for Pla inhibition to obtain IC50. Structure-activity relationship (SAR) study of the lead analogs can provide useful information to …

    houston Repository record for I) SYNTHESIS OF PLASMINOGEN ACTIVATOR (Pla) INHIBITORS IN YERSINIA PESTIS II) DEVELOPMENT OF SMALL MOLECULE INHIBITORS TO RESTORE NUCLEAR p27 AS A THERAPEUTIC METHOD FOR ENDOMETRIAL CANCER (opens in a new tab)

  15. Design and synthesis of potential antimicrobial agents

    … a database of commercially available drug-like compounds. From these results new potential ligands were designed that fitted appropriately into the active site and matched the functional groups and binding motifs founds therein. Some of these compounds and close analogues were then synthesized …

    aston Download PDF for Design and synthesis of potential antimicrobial agents (opens in a new tab)

  16. Design and Synthesis of 8-Trifluoromethyl-Substituted Heterocyclic Small Molecule Mitochondrial Uncouplers for the Treatment of Metabolic Diseases

    … 8-trifluoromethyl-9H-purin-6- amines where lead compound SHK1112218 was identified as a highly potent mitochondrial uncoupler. Additionally, in an obesity reversal study in mice, treatment with lead compound SHK589 was observed to decrease body fat and maintain muscle mass. Together, these …

    vt Repository record for Design and Synthesis of 8-Trifluoromethyl-Substituted Heterocyclic Small Molecule Mitochondrial Uncouplers for the Treatment of Metabolic Diseases (opens in a new tab)

  17. Developments in Thieno[3,2-c]isoquinoline Analogues as Potential Anti-Cancer Agents

    Chemotherapies are the leading treatment for late-stage cancers. Despite their efficacy, these treatments are known to have harsh side effects caused by poor selectivity for cancerous cells over healthy cells. For this reason, the exploration of molecular targets specific to cancer cells is crucial …

    concordia Download PDF for Developments in Thieno[3,2-c]isoquinoline Analogues as Potential Anti-Cancer Agents (opens in a new tab)

  18. The Synthesis and study of heterocyclic, dimeric and chiral ligands for the multidrug-resistance transporter

    … to develop MDR. There are multiple factors that lead to MDR but the factor that we will be exploring in this dissertation is the expression of multiple drug resistance gene 1 and the over expression of multi drug resistance protein 1(MDR1, also known as P-glycoprotein or P-gp). MDR1 has also been …

    montana Repository record for The Synthesis and study of heterocyclic, dimeric and chiral ligands for the multidrug-resistance transporter (opens in a new tab)

  19. The Synthesis and study of heterocyclic, dimeric and chiral ligands for the multidrug-resistance transporter

    … to develop MDR. There are multiple factors that lead to MDR but the factor that we will be exploring in this dissertation is the expression of multiple drug resistance gene 1 and the over expression of multi drug resistance protein 1(MDR1, also known as P-glycoprotein or P-gp). MDR1 has also been …

    montana-tech Repository record for The Synthesis and study of heterocyclic, dimeric and chiral ligands for the multidrug-resistance transporter (opens in a new tab)

Page 1 of 20